The cost of cytokines
Avril, M.F.
La Revue du Praticien 43(5): 594-597
1993
ISSN/ISBN: 0035-2640 PMID: 8341930 Document Number: 405324
The use of cytokines (interferons, interleukin-2, growth factors) is in full development, but the new drugs issued from biotechnology are costly. In order to control consumption, these products are made available only to hospital pharmacists, and they are paid by the prescribing establishments from global funds. This results in an ever growing financial burden on the hospital pharmaceutical budget. Physicians will have to conciliate 2 objectives: make the patients benefit from the new drugs, and control the expenses by using these drugs only when necessary.
Document emailed within 1 workday
Related Documents
Nikankina, L.V.; Dolgina, E.N.; Gankovskaia, L.V.; Klebanov, G.I.; Koval'chuk, L.V. 1999: The modulation of phagocyte oxygen metabolism by recombinant cytokines and a complex of natural cytokines Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 106-108Tonouchi, N.; Matsui, H. 1988: Problems in the clinical application of human recombinant cytokines. Present condition and types of mass-production of cytokines Nihon Rinsho. Japanese Journal of Clinical Medicine 46(5): 1074-1079
Larsen, C.; Zachariae, C.; Mukaida, N.; Anderson, A.; Yamada, M.; Oppenheim, J.; Matsushima, K. 1990: Proinflammatory cytokines interleukin 1 and tumor necrosis factor induce cytokines that are chemotactic for neutrophils, T cells and monocytes Progress in Clinical and Biological Research 349: 419-431
Kanaya, M.; Tanaka, S. 1994: A role of cytokines produced by allostimulated lymphocytes on maintenance of pregnancy--enhancement of trophoblast proliferation and beta-hCG secretion by cytokines Nihon Sanka Fujinka Gakkai Zasshi 46(6): 489-496
Shade, S.B.; Kevany, S.; Onono, M.; Ochieng, G.; Steinfeld, R.L.; Grossman, D.; Newmann, S.J.; Blat, C.; Bukusi, E.A.; Cohen, C.R. 2013: Cost, cost-efficiency and cost-effectiveness of integrated family planning and HIV services Aids 27(Suppl 1): S87-S92
Hudecková, H.; Straka, S.; Szilágyiová, M.; Avdicová, M.; Rusnáková, S. 2002: Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic Central European Journal of Public Health 10(4): 146-148
Kahn, J.G.; Jiwani, A.; Gomez, G.B.; Hawkes, S.J.; Chesson, H.W.; Broutet, N.; Kamb, M.L.; Newman, L.M. 2014: The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model PLOS one 9(1): E87510
Mielck, A. 1988: Cost-effectiveness and cost-benefit approaches in programs designed to prevent AIDS Aids and Public Policy Journal 3(3): 19-22
Drummond, M.F. 1985: Survey of cost-effectiveness and cost-benefit analyses in industrialized countries World Health Statistics Quarterly. Rapport Trimestriel de Statistiques Sanitaires Mondiales 38(4): 383-401
Deirdre Wulf 1981: Cost-Benefit and Cost-Effectiveness Analysis for Family Planning Programs International Family Planning Perspectives 7(4): 141-144
Wilson, L. 2008: The cost of errors. Medicare's new policy could cost the average hospital $23,772: study Modern Healthcare Suppl: 8-9
Tremblay, J. 1980: Prescription drugs and the aged: cost-free and cost-containment measures L'Union Medicale du Canada 109(3): 414-420
Rauh, S.S.; Wadsworth, E.; Weeks, W.B. 2010: The fixed-cost dilemma: what counts when counting cost-reduction efforts? Healthcare Financial Management: Journal of the Healthcare Financial Management Association 64(3): 60-63
Merritt, T.A.; Hallman, M.; Vaucher, Y.; McFeeley, E.; Tubman, T.R. 1990: Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis Journal of Perinatology: Official Journal of the California Perinatal Association 10(4): 416-419
Walker, D. 2003: Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base? Health Policy and Planning 18(1): 4-17
Granich, R.; Kahn, J.G.; Bennett, R.; Holmes, C.B.; Garg, N.; Serenata, C.; Sabin, M.Lewis.; Makhlouf-Obermeyer, C.; De Filippo Mack, C.; Williams, P.; Jones, L.; Smyth, C.; Kutch, K.A.; Ying-Ru, L.; Vitoria, M.; Souteyrand, Y.; Crowley, S.; Korenromp, E.L.; Williams, B.G. 2012: Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050 PloS one 7(2): e30216
Marseille, E.; Giganti, M.J.; Mwango, A.; Chisembele-Taylor, A.; Mulenga, L.; Over, M.; Kahn, J.G.; Stringer, J.S.A. 2012: Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia Plos one 7(12): E51993
Wessels, F.; Anderson, A.N.; Kropman, K. 1999: The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. a cost-minimisation pharmaco-economic model South African Medical Journal 89(7 Part 2): 791-794
Di Pasquale, C. 1983: Various methods for community fluoridation--the situation in Africa. (A comparative study on cost benefits and cost effectiveness.) Odonto-Stomatologie Tropicale 6(1): 7-18
Bassett, I.V.; Govindasamy, D.; Erlwanger, A.S.; Hyle, E.P.; Kranzer, K.; van Schaik, N.; Noubary, F.; Paltiel, A.D.; Wood, R.; Walensky, R.P.; Losina, E.; Bekker, L.-G.; Freedberg, K.A. 2014: Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness Plos one 9(1): E85197